Biomarkers and causes of lung injury from reflux
Part of Infections, Lungs & breathing clinical trials.
This study looks at why some people on breathing tubes develop lung damage from stomach acid getting into the lungs. It may help find better ways to prevent or treat this injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 99 years old
- You have been diagnosed with ARDS (a serious lung injury) and need a breathing tube
- A lung exam (bronchoscopy) is planned within 24 hours of starting the breathing tube
- You do not have heart failure, active cancer, stomach bleeding, or a weak immune system
- You are not taking certain medications like steroids or NSAIDs (e.g., ibuprofen) in the last day
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how immune cells in the lungs and gut microbes (your microbiome) change during ARDS and how these changes relate to your outcomes. It may help researchers better predict and treat ARDS by learning what’s going on in the lungs and body systems.
This study looks at two substances in saliva and lung fluid—called IL-6 and TNF-α—in children with severe lung failure (ARDS) who are on a breathing machine. Measuring these markers may help doctors better understand the condition and guide treatment.
This study looks at better ways to protect the lungs during mechanical ventilation (breathing support) for people with ARDS, a serious lung injury. It aims to find ways to reduce additional damage to the lungs while on a ventilator.
This study looks for markers in the blood and signs of air trapped in the lung tissue of people with acute respiratory distress syndrome (ARDS). It uses CT scans to understand why air leaks happen and if certain lab tests can predict them.
This trial looks at how the immune system might cause severe breathing problems (ARDS). It may help doctors understand what happens in the lungs during this condition and find better ways to treat it.
This study looks at a specific breathing event (“avalanche phenomenon”) when the lungs are opened in people with early, moderate-to-severe ARDS. The goal is to understand what’s happening in the lungs and whether it can guide better care.
Hear when a new ARDS, Human trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.